The independent source for health policy research, polling, and news.
381 - 400 of 734 Results
Investigators allege a Texas company that arranges spine surgery and other medical care for people injured in car crashes accepted bribes in violation of 1960s-era racketeering law.
Health and Human Services Secretary Xavier Becerra is drawing criticism for his hands-off handling of the covid crisis even though the heads of the Centers for Disease Control and Prevention, National Institutes of Health, and FDA report to him. Meanwhile, the Department of Labor looks to enforce mental health parity laws that have failed to achieve their goals. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico, and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Noam N. Levey, who reported and wrote the latest KHN-NPR Bill of the Month episode about a large emergency room bill for a small amount of medical care.
If federal officials accept a courts decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
Temporary subsidies helped boost enrollment under the Affordable Care Act to a record 14.5 million, according to the Department of Health and Human Services. But unless Democrats in Congress extend those subsidies, many of those new enrollees will be in for a rude surprise just ahead of midterm elections. Meanwhile, the need to replace retiring Supreme Court Justice Stephen Breyer further crowds an already tight legislative schedule. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet, and Anna Edney of Bloomberg News join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Diana Greene Foster, author of The Turnaway Study: Ten Years, a Thousand Women, and the Consequences of Having Or Being Denied An Abortion.
Jan. 22 marks the 49th and very likely last anniversary of the Supreme Courts landmark abortion decision, Roe v. Wade. The courts conservative supermajority seems poised to overturn later this year the ruling that legalized abortion nationwide. Also this week, the Biden administration turns 1, with much of its domestic and health agenda yet unrealized. Alice Miranda Ollstein of Politico, Shefali Luthra of the 19th, and Kimberly Leonard of Insider join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Marjorie Dannenfelser, president of the Susan B. Anthony List, about what a post-Roe world might look like.
The Supreme Court temporarily blocked a federal rule requiring larger businesses to mandate employees be vaccinated or wear masks and undergo weekly testing. At the same time, however, it allowed a federal order that health care workers be vaccinated.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimers drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more.
On Jan. 1, California started buying prescription drugs for its nearly 14 million Medicaid enrollees, a responsibility that had primarily been held by managed-care insurance plans. State officials estimate California will save hundreds of millions of dollars by flexing its purchasing power, but some health clinics expect to lose money.
The court is considering whether to let the rules go into effect as opponents fight them in lower courts. Conservative justices pressed lawyers hard about whether the administration overstepped its authority, but liberal members of the high court questioned why the government shouldnt be expected to move forcefully when facing a severe health crisis.
If a judge decides someone cannot make their own decisions, the person can be placed under a court-appointed guardianship, also known as a conservatorship. Some states are beginning to allow less-restrictive alternatives.
Its 2022 and the covid-19 pandemic is still with us, as are congressional efforts to pass President Joe Bidens big health and social spending bill. But other issues seem certain to take center stage on this years health agenda, including abortion, the state of the health care workforce, and prescription drug prices. Tami Luhby of CNN, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Victoria Knight, who reported the latest KHN-NPR Bill of the Month episode.
The letters function as liens that protect spine surgery clinics while patients could be left with inflated medical bills and unexpected health risks.
Even before the omicron variant of covid starts to spread widely in the U.S., hospitals are filling up with post-holiday delta cases. Meanwhile, the Supreme Court signals loudly that 2022 will be the year it rolls back abortion rights in a big way. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Ellen McIntire of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more.
The decision does not address the fate of abortion rights nationally, but the justices took up those arguments in a separate case earlier this month that will likely be decided in the summer.
The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didnt know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.
The fight over covid vaccines continues to intensify, with Republicans on Capitol Hill pushing with some success to cancel President Joe Bidens test regularly or vaccinate requirement for private employers. Meanwhile, abortion is not the only health issue before the Supreme Court this term. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat News join KHNs Julie Rovner to discuss these issues and more.
A Supreme Court majority appears ready to overturn nearly 50 years of abortion rights, at least judging by the latest round of oral arguments before the justices. And a new covid variant, omicron, gains attention as it spreads around the world. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet and Shefali Luthra of The 19th join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Blake Farmer of Nashville Public Radio about the latest KHN-NPR Bill of the Month episode.
A majority of the members of the Supreme Court seemed sympathetic Wednesday during arguments to Mississippis assertion that the landmark Roe v. Wade decision, which legalized the procedure throughout the country, was wrongly decided.
President Joe Bidens social spending budget is on its way to the U.S. Senate, where Democratic leaders are (optimistically) hoping to complete work by the end of the year. Meanwhile, covid is surging again in parts of the country, along with the political divides it continues to cause. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins School of Public Health, and Mary Agnes Carey of KHN join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner previews next weeks Supreme Court abortion oral arguments with Florida State University law professor Mary Ziegler.
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimers disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the An Arm and a Leg podcast.
穢 2026 KFF